Results 161 to 170 of about 262,665 (314)

Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients [PDF]

, 1985
Arto Alanko, Erkki Heinonen, T. M. Scheinin, Esa‐Matti Tolppanen, Reijo Vihko   +4 more
openalex   +1 more source

Emerging Nanozyme Strategies for Precision Breast Cancer Treatment

Advanced Science, EarlyView.
Different types of nanozymes‐mediated chemotherapy, photothermal therapy, immunotherapy, and multiple combined therapies for the effective treatment of breast cancer. Abstract Breast cancer, the most common malignant tumor among women worldwide, poses a significant challenge to public health due to its high incidence and mortality rates.
Jian Zang, Zhaozhou Ren, Haibo Wang, Xing Yang, Yang Song, Jun Liao, Xiaoying Li   +6 more
wiley   +1 more source

Prognostic value of FOXA1 in estrogen receptor-negative breast cancer: A systematic review and meta-analysis. [PDF]

PLoS One
Fonseca-Benitez AV, Díaz-Báez D, Guevara-Pulido J, Rondón-Lagos M, Aristizábal-Pachón AF, Rangel N.   +5 more
europepmc   +1 more source

Spatial Transcriptomics and snRNA‐seq Expose CAF Niches Orchestrating Dual Stromal‐Immune Barriers in Hepatocellular Carcinoma

Advanced Science, EarlyView.
HmmyCAFs may form a triple immunosuppressive niche: possibly secrete ECM (POSTN, etc.) as physical barriers to block CD8⁺ T cells, induce CD8⁺ T exhaustion via those molecules, and use HIF‐1α‐driven metabolism to create acidic, nutrient‐poor microenvironments that suppress T cells.
Yingxue Li, Changxiang Huan, Haoting Sun, Wei Zhang, Zhen Guo, Chuanyu Li, Jia Yao, Zhiqi Zhang, Shizhe Yu, Qiongzhu Dong, Lunxiu Qin, Jinze Li, Lianqun Zhou   +12 more
wiley   +1 more source

G-Protein-Coupled Estrogen Receptor (GPER) in Inflammatory Myopathies. [PDF]

Neurol Int
Righi D, Lopergolo D, Volpi N, Franci D, Lorenzoni P, Aglianò M, Berti G, Manco C, De Stefano N, Ginanneschi F.   +9 more
europepmc   +1 more source

Rat ovarian angiotensin II receptors. Characterization and coupling to estrogen secretion.

, 1987
Anthony G. Pucell, F. Merlin Bumpus, Ahsan Husain   +2 more
openalex   +1 more source

Evaluation of an enzyme immunoassay kit for estrogen receptor measurements. [PDF]

, 1986
Shanthi Raam, D M Vrabel
openalex   +1 more source

Pushing Biomolecule Detection Limit With Graphene Field‐effect Transistor Biosensors

Advanced Electronic Materials, EarlyView.
Graphene knows your health! This work presents a comprehensive overview of recent advances in graphene field‐effect transistor (GFET) biosensors for ultrasensitive biomolecule detection. How device engineering, high‐mobility graphene synthesis, and tailored surface chemistry push detection limits is highlighted, while discussing emerging strategies ...
Co Dang Pham, Quang Thang Trinh, Jun Zhang, Nam‐Trung Nguyen, Tuan‐Khoa Nguyen   +4 more
wiley   +1 more source

Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD). [PDF]

ACS Omega
Ng RA, Barratt S, Parisian A, Palanisamy GS, Phukan S, Sun R, Robello B, Peña G, Sapugay J, Yeghikyan D, Wang C, Satish Kher S, Thangathirupathy S, Millikin R, Yu G, Watanabe T, Zhou F, Rich B, Duncan A, Andersen SE, Chawla R, Zak DR, Heerding DA, Hearn BR, Greene G, Harmon CL, Hodges-Gallagher L, Kushner PJ, Fanning SW, Myles DC.   +29 more
europepmc   +1 more source

Relationship of quantitative estrogen-receptor level and clinical response to cytotoxic chemotherapy in advanced breast cancer. An extramural analysis [PDF]

, 1984
Donald K. Corle, Mary E. Sears, Kenneth B. Olson   +2 more
openalex   +1 more source